GB Sciences Inc (GBLX)

[Supermeatball]

On March 7, 2018, a special meeting of the Registrant was called to order and then adjourned and continued until April 6, 2018, because on March 7, 2018, an insufficient number of votes were present at the meeting to consitute a quorum for purposes of taking shareholder action. As of the record date for the meeting there were 134,566,238 common shares issued and outstanding. There were 85,936,499 common shares represented at the reconvened meeting on April 6, 2018, either in person or by proxy.
With regard to the proposal to approve the change in corporate domicile from the State of Delaware to the State of Nevada, the vote was 84,759,618 for; 995,374 against; and 181,507 abstaining.
With regard to the proposal to approve an amendment to our articles of incorporation to increase the number of authorized capital shares from 250,000,000 to 400,000,000, the vote was 78,137,590 for; 7,183,703 against; and 615,206 abstaining.
With regard to the proposal to ratify the adoption by the board of the Growblox Sciences, Inc. 2014 Equity Incentive Plan, the vote was 84,759,618 for; 995,374 against; and 181,507 abstaining.
With regard to the proposal to lower the quorum requirement for shareholder meeting purposes from 50% to 33%, the vote was 84,759,618 for; 995,374 against; and 181,507 abstaining.
With regard to the proposal to authorize the board of directors to designate classifications of stock from the authorized capital stock of the company and to designate series of stock within those classifications and to designate the rights and privileges of those series, the vote was 84,759,618 for; 995,374 against; and 181,507 abstaining.

https://www.sec.gov/Archives/edgar/data/1165320/000093979818000018/gblxeightkfivezeroseven.htm